who-istock-481275412

godfather744431 / iStockphoto.com

18 March 2019Americas

WHO and UN actions undermine IP and hurt innovation, warns PhRMA

Supranational organisations such as the World Health Organization (WHO) and the United Nations Development Program (UNDP) are promoting acts, policies and practices that prevent biopharmaceutical innovators from securing and maintaining patents.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

20 February 2018 Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”.

PhRMA urges USTR to protect US innovation abroad

13 February 2017 The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.

More on this story

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

20 February 2018 Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”.

PhRMA urges USTR to protect US innovation abroad

13 February 2017 The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.

More on this story

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

20 February 2018 Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”.

PhRMA urges USTR to protect US innovation abroad

13 February 2017 The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.

More features

LSPN: In-house ‘chess game’ is the same, but the rules have changed

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims